"The Government has taken steps to increase the volume of research in Unani system of medicines and develop safe and cost effective treatment for various deadly diseases.
"...Time bound research projects have been allotted under the Intramural Research policy, greater emphasis has been laid on undertaking collaborative research studies with reputed scientific organisations and allopathic hospital like AIIMS, New Delhi," Minister of State, AYUSH, Shripad Yesso Naik said in a written reply in Rajya Sabha.
Elaborating on other steps, Naik said that randomised control trials in different non-communicable diseases such as diabetes mellitus, hypertension, vitiligo have been carried out at different institutes under Central Council for Research in Unani Medicine (CCRUM).
He said that CCRUM has conducted validaton of Unani pharmacopoeial formulations in ten diseases till now.
"Central Council for Research in Unani Medicine (CCRUM), an autonomous organization under AYUSH Ministry, is engaged in the scientific validation of Unani pharmacopoeial formulations in various diseases since 2012.
"So far validation studies on 20 pharmacopoeial formulations in 10 disease conditions have been completed and in another 41 formulations in 27 disease conditions is in progress," he said.
The Ministry has established CCRUM with the mandate to undertake research and development of Unani Medicine through its 23 Central Research Institutes.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
